MISSION
Overcoming your market access challenges together
At Axios Partners, we are driven by our passion for innovation, challenge and access. Our purpose is to ensure that groundbreaking products not only reach the market quickly but also become accessible to all eligible patients, providing fair and sustainable access while delivering the best value.
With decades of expertise, our mission is to help healthcare companies and organizations navigate the complex and ever-evolving regulatory and market access landscape for medicines and medical technologies.
EXPERTISE
Market Access
Solving access challenges through unrivaled expertise combining strategic mindsets
with strong technical capabilities
Early Access
We provide strategic and operational support to define and execute the optimal market access pathway for launching your innovation in France – whether through compassionate access, early access or direct access
Discover more
HTA Assessment
We offer comprehensive operational support, including the development of HAS Transparency Committee dossiers, facilitation of Market Access Advisory Boards, hearing preparation, and end-to-end assistance throughout the HTA process
Discover more
Pricing and Market Access Strategy
We partner with you to develop tailored market access and pricing strategies to ensure the successful launch of your innovation in France
Discover more
Pricing Negotiation
We partner with you through each step of the pricing negotiation process, aligning your priorities with CEPS expectations to secure successful pricing outcomes
Discover more
Early Dialogue
We help you request and prepare for early dialogues with the HAS, ensuring your clinical development plan is aligned with their expectations
Discover more
Safeguard Contribution
We provide expert guidance on the Safeguard Clause – from helping you understand its core principles and anticipated legislative changes to forecasting your financial contribution
Discover moreBENEFITS
Why choose AXIOS Partners ?
Senior-Only Team
All our consultants are experts in market access with 15+ to 25+ years of experience. No juniors—your project is handled exclusively by senior experts from start to finish.
End-To-End Strategic
and Operational Support
We provide strategic advice, from clinical trial design to price negotiation – ensuring alignment between clinical evidence and payer expectations – and we provide operational support at all stages – ensuring the perfect execution of the market access strategy.
Specialists in Complex Therapies
We bring deep, hands-on expertise with challenging assets, including orphan drugs, onco-hematology products, gene therapies, combination therapies and vaccines.
Proven Negotiation Skills
We’re known for our strong track record of successful pricing negotiations, especially in challenging therapeutic areas.
Deep Understanding
of the French Landscape
We have a thorough understanding of the French market access pathways
(early access, compassionate access,
direct access, common law), pricing rules, and stakeholder expectations—essential for navigating the complex and ever-evolving environment.
Seamless Teamwork, Built Over Time
We have worked together closely for years, creating a unique team dynamic that ensures consistency, agile collaboration, and high execution quality.
TEAM
